JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A4394 Docetaxel
9 Citation

Summary: Microtubulin disassembly inhibitor

≥40.4 mg/mL
A3124 5-hydroxypyrazine-2-carboxylic acid

Summary: Metabolite of pyrazinamide (PZA)

insoluble in EtOH; ≥7 mg/mL
A3256 BMS-690514

Summary: HER/EGFR inhibitor

Soluble in DMSO
A3268 CAL-130 Hydrochloride

Summary: PI3K inhibitor

Soluble in DMSO
A3317 Clozapine N-oxide (CNO)
42 Citation

Target: DREADD Ligands

Summary: Metabolite of clozapine

insoluble in EtOH and H2O; ≥17.15 mg/mL
A3336 CVT-313
1 Citation

Target: Cyclin-Dependent Kinases

Summary: Cdk2 inhibitor

≥20 mg/mL
A3355 Deferasirox Fe3+ chelate

Summary: Oral iron chelator

Soluble in DMSO
A3424 Gambogic Acid

Summary: Caspase activator and apoptosis inducer

≥22.45 mg/mL
A3522 Kaempferide

Summary: O-methylated flavonol

insoluble in H2O; insoluble in EtOH; ≥16.53 mg/mL
A3750 Regorafenib hydrochloride

Target: Raf|VEGFR|PDGFR|c-Kit|c-RET

Summary: Tyrosine kinase inhibitor

≥25.95 mg/mL